The patient was admitted to a negative pressure room, received intravenous tissue plasminogen activator (tPA), and was started on anticoagulation with heparin, azithromycin, and ceftriaxone for coverage of COVID-19 associated pneumonia and community-acquired pneumonia. The gene discussed is PLAT; the disease is pneumonia.